“…Knock-out models include an astrocytic-specific Cx43 knock-out, a Cx30 knock-out, a double knock-out targeting both astrocytic connexins, as well as a knock-in model of Cx43G138R [10, [75][76][77]. Together with pharmacological experiments, these mouse models have yielded insights about the diverse roles of these connexin hemichannels, both in normal and pathological situations (e.g., vasoconstriction, synaptic transmission, modulation of excitability of sensory neurons, Alzheimer's disease, neuropathic pain, cell damage in brain trauma, ischemic stroke, HIVmediated brain dysfunction, and brain alterations following prenatal nicotine exposure, [17, 21, [78][79][80][81][82][83][84][85]). The downside of the gene alteration strategy is the frequent discovery of inadvertent effects on other factors in these mice: The widespread transcriptome alterations observed in mice with knock-out or knock-down of Cx43 [86,87] can, in some cases, lead to changes in membrane transport mechanisms unrelated to Cx43, but which may then be mistakenly construed to be Cx43 effects.…”